| Sandoz Pharmaceuticals AG - Co-Amoxicillin Sandoz i.v. 2,2 g, Pulver zur Herstellung einer Injektions-/Infusionslösung |
| 56311 | | 02 | | Co-Amoxicillin Sandoz i.v. 2,2 g | | Pulver zur Herstellung einer Injektions-/Infusionslösung | | J01CR02 | | Amoxicillin and Beta-Lactamase Inhibitor | | 10.12.2004 | | |
|
| Composition |
| Praeparatio sicca: amoxicillinum anhydricum 2 g ut amoxicillinum natricum, acidum clavulanicum 200 mg ut kalii clavulanas, pro vitro. |
| Packungsbestandteile |
| Powder for injection- or infusion solution | | | | | | Active Agent | Dose | additional_information |
|---|
| Clavulanic Acid | 200 mg correspond Potassium Clavulanate | | | Amoxicillin Anhydride | 2 g correspond Amoxicillin Sodium | Praeparatio sicca |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
